My Monograph -> Induction of benzonidazole resistance in human isolates of Trypanosoma cruzi @ Inflammatory processes may play role in ALS – FDA-approved drug shows promise against the neurodegenerative disease in mice @ Stem Cell Therapy Helps Broken Hearts Heal in Unexpected Way – Study in Nature Sheds New Light on Heart Attack Treatment Controversy @ Virgina Niemi – Not just a gut feeling: Improving animal models of colorectal cancer @ TBT 10/8/19 – The Mouse Cancer from vaping – news roundup – Jerome Adams MD @ Anti-tumor immune therapy for colon cancer works in mice, says new study & Altogen Labs Hs746T Xenograft Service Gastric Cancer @ https://en.wikipedia.org/wiki/Monograph @ ´´A strain, in reference to rodents, is a group in which all members are as nearly as possible genetically identical. In laboratory mice, this is accomplished through inbreeding. By having this type of population, it is possible to conduct experiments on the roles of genes, or conduct experiments that exclude genetic variation as a factor.´´ https://en.wikipedia.org/wiki/Laboratory_mouse @ VERY IMPORTANT INFORMATION LIKE VIDEOS, SOCIAL NETWORKS, WEBSITES, LINKS AND IMAGES

Do the downloads !!! Share!! Thanks!!

´´The world people need to have very efficient researches and projects resulting in very innovative drugs, vaccines, therapeutical substances, medical devices and other technologies according to the age, the genetics and medical records of the person. So, the treatment, disgnosis and prognosis will be very efficient and better, of course´´. Rodrigo Nunes Cal

https://science1984.wordpress.com/2021/08/14/do-the-downloads-of-very-important-detailed-and-innovative-data-of-the-world-about-my-dissertation-like-the-graphics-i-did-about-the-variations-of-weights-of-all-mice-control/

Mestrado – Dissertation – Tabelas, Figuras e Gráficos – Tables, Figures and Graphics


Impact_Fator-wise_Top100Science_Journals

GRUPO_AF1

GRUPO_AF2

GRUPO AFAN 1

GRUPO AFAN 2

Slides – mestrado

CARCINÓGENO DMBA EM MODELOS EXPERIMENTAIS

Avaliação da influência da atividade física aeróbia e anaeróbia na progressão do câncer de pulmão experimental – Summary – Resumo

https://www.cincinnatichildrens.org/news/release/2019/stem-cell-therapy https://news.harvard.edu/gazette/story/2019/11/fda-approved-drug-shows-promise-against-als-in-mice/

https://science1984.wordpress.com/2018/07/15/my-monography-chagas-disease-research-in-laboratory-2/

INDUÇÃO DE RESISTÊNCIA AO BENZONIDAZOL EM ISOLADOS HUMANOS DE TRYPANOSOMA CRUZI -> https://science1984.files.wordpress.com/2018/03/monografia-monography.pdf

http://slideplayer.com.br/slide/7306497/

Gratidão – Gratitude – Vídeo – Video: Convites p/ eu participar de eventos científicos muito importantes do mundo em pouco tempo – Gratitude: I am very grateful because I was invited by Internet through direct messages to participate in 55 very important science events in the world in 25 cities in less than 1 year.

Skip to content

The Harvard Gazette

Search for:

The Daily Gazette

Sign up for daily emails to get the latest Harvard news.

Harvard University

  •  
  •  
  •  
  •  

Campus & Community

 

The turkeys of Harvard

 

Notes of gratitude, gifts of charity

Health & Medicine

 

Inflammatory processes may play role in ALS

 

CAGEs lock up fats to treat obesity

Featured

© 2019 The President and Fellows of Harvard College

Powered by WordPress.com VIP

The Harvard Gazette

Inflammatory processes may play role in ALS

CAGEs lock up fats to treat obesity

Health & Medicine

Inflammatory processes may play role in ALS

3d illustration of nervous network and nerve cells in blue.
Following treatment with an anti-inflammatory drug, the onset of ALS was delayed in a mouse model. ALS affects nerve cells (pictured) in the brain and spinal cord. iStock

FDA-approved drug shows promise against the neurodegenerative disease in mice

By MGH News and Public Affairs

DateNovember 27, 2019Share

Trending

  1. 7 Harvard seniors named Rhodes Scholars
  2. Speeding cell, gene therapy development
  3. The turkeys of Harvard
  4. Good genes are nice, but joy is better
  5. Music everywhere

The cause of amyotrophic lateral sclerosis (ALS) — a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death — is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

In research led by investigators at Harvard-affiliated Massachusetts General Hospital (MGH) and published in Scientific Reports, treatment with an anti-inflammatory drug delayed the onset of disease in a mouse model of ALS.

Only two treatments are approved by the U.S. Food and Drug Administration (FDA) to treat ALS, and they are only modestly effective. Recent studies from MGH demonstrated that cromolyn sodium, an FDA-approved compound used to treat asthma and other conditions, exerts neuroprotective effects in cellular and animal models of Alzheimer’s disease.

To test the therapeutic potential of the drug against ALS, a team injected cromolyn sodium into male and female mice with and without a genetic mutation that causes ALS. The team was led by Ghazaleh Sadri-Vakili, director of the NeuroEpigenetics Laboratory at the Sean M. Healey and AMG Center for ALS and the MassGeneral Institute for Neurodegenerative Disease, in collaboration with Healey Center and MGH colleagues.

Related

 

Interaction between immune factors can trigger cancer

Blocking it prevents development of skin and colon cancers in mice with chronic inflammation

Inflammation reduction cuts risk of heart attack, stroke

Trial study finds need for expensive interventions, such as bypass surgery, cut by more than 30 percent

Exercise reduces chronic inflammation, protects heart, study says

After six weeks, mice had lower levels of inflammatory leukocytes

In addition to observing that the treatment delayed the development of disease symptoms in the mice carrying the ALS mutation, the researchers demonstrated that it protected neurons from degenerating and helped maintain the connections between nerves and muscles. Also, cromolyn sodium reduced inflammation surrounding muscles by targeting specific immune cells, called mast cells, and decreased pro-inflammatory markers both in the spinal cord and the blood.

“Our study supports the notion that inflammation has a significant role in the progression of ALS and therefore exploring anti-inflammatory treatments may be of great value for developing an effective treatment,” said Sadri-Vakili. “Our findings demonstrate that cromolyn treatment provides neuroprotection in a mouse model of ALS. It remains to be seen whether these effects will translate to people living with the disease. Therefore, we will continue to explore inflammation’s role in disease development and progression in hopes of translating this research into potential ALS treatments.”

This work was supported by Project ALS.

Editor’s Picks

 

News

7 Harvard seniors named Rhodes Scholars

Two others awarded George J. Mitchell Scholarships

Arts

Hip-hop steps up

Combining dance with a look at the social and cultural history of the genre

Campus

The turkeys of Harvard

Wild birds roam many parts of the campusUp
Next Health & Medicine CAGEs lock up fats to treat obesity

  •  
  •  
  •  
  •  

GivingScheduleMyChartInternational

Cincinnati Childrens

Newsroom

Newsroom

Stem Cell Therapy Helps Broken Hearts Heal in Unexpected Way

Study in Nature Sheds New Light on Heart Attack Treatment Controversy

Wednesday, November 27, 2019

Macrophages to the Rescue

A microscopic histology image of macrophage immune cells.

In this microscopic histology image, macrophage immune cells (shown in red and green) flock to the injured region of a damaged mouse heart three days after researchers injected adult heart stem cells within the yellow dotted area. Researchers report Nov. 27 in Nature that stem cell therapy helps hearts recover from heart attack by triggering an innate immune response that alters cell activity around the injured area so that it heals with a more optimized scar and improved contractile properties.

Stem cell therapy helps hearts recover from a heart attack, although not for the biological reasons originally proposed two decades ago that today are the basis of ongoing clinical trials. This is the conclusion of a Nov. 27 study in Nature that shows an entirely different way that heart stem cells help the injured heart – not by replacing damaged or dead heart cells as initially proposed.

The study reports that injecting living or even dead heart stem cells into the injured hearts of mice triggers an acute inflammatory process, which in turn generates a wound healing-like response to enhance the mechanical properties of the injured area.

Mediated by macrophage cells of the immune system, the secondary healing process provided a modest benefit to heart function after heart attack, according to Jeffery Molkentin, PhD, principal investigator, director of Molecular Cardiovascular Biology at Cincinnati Children’s Hospital Medical Center and a professor of the Howard Hughes Medical Institute (HHMI).

“The innate immune response acutely altered cellular activity around the injured area of the heart so that it healed with a more optimized scar and improved contractile properties,” Molkentin said. “The implications of our study are very straight forward and present important new evidence about an unsettled debate in the field of cardiovascular medicine.”

The new paper builds on a 2014 study published study by the same research team, also in Nature. As in that earlier study, the current paper shows that injecting c-kit positive heart stem cells into damaged hearts as a strategy to regenerate cardiomyocytes doesn’t work. The findings prompted Molkentin and his colleagues to conclude that there is a need to “re-evaluate the current planned cell therapy based clinical trials to ask how this therapy might really work.”

An Unexpected Discovery

The study worked with two types of heart stem cells currently used in the clinical trials—bone marrow mononuclear cells and cardiac progenitor cells. As the researchers went through the process of testing and re-verifying their data under different conditions, they were surprised to discover that in addition to the two types of stem cells, injecting dead cells or even an inert chemical called zymosan also provided benefit to the heart by optimizing the healing process. Zymosan is a substance designed to induce an innate immune response.

Researchers reported that stem cells or zymosan therapies tested in this study altered immune cell responses that significantly decreased the formation of extra cellular matrix connective tissue in the injury areas, while also improving the mechanical properties of the scar itself. The authors concluded: “injected hearts produced a significantly greater change in passive force over increasing stretch, a profile that was more like uninjured hearts.”

Molkentin and his colleagues also found that stem cells and other therapeutic substances like zymosan have to be injected directly into the hearts surrounding the area of infarction injury. This is in contrast to most past human clinical trials that for patient safety reasons simply injected stem cells into the circulatory system.

“Most of the current trials were also incorrectly designed because they infuse cells into the vasculature,” Molkentin explained. “Our results show that the injected material has to go directly into the heart tissue flanking the infarct region. This is where the healing is occurring and where the macrophages can work their magic.”

The researchers also noted an interesting finding involving zymosan, a chemical compound that binds with select pattern recognition receptors to cause an acute innate immune response. Using zymosan to treat injured hearts in mice resulted in a slightly greater and longer-lasting benefit on injured tissues than injecting stem cells or dead cell debris.

Looking to the Future

Molkentin said he and other collaborating scientists will follow up the findings by looking for ways to leverage the healing properties of the stem cells and compounds they tested.

For example, considering how heart stem cells, cell debris and zymosan all triggered an acute innate immune response involving macrophages in the current paper, Molkentin explained they will test a theory that harnesses the selective healing properties of macrophages. This includes polarizing or biologically queuing macrophages to only have healing-like properties.

Further testing of this, he said, could therapeutically be very important for developing future treatment strategies.

The study’s first author was Ronald Vagnozzi, PhD, a fellow and investigator in the Molkentin Lab. Key collaboration also came from scientists in the Cincinnati Children’s Heart Institute, the University of Cincinnati Department of Pediatrics and the Center for Systems Biology (Department of Imaging) and the Cardiovascular Research Center at Massachusetts General Hospital and Harvard Medical School in Boston.

Funding support for the study came in part by grants from the National Institutes of Health (R01 HL132391) and an NIH Research Service Award via the National Heart Blood and Lung Institute (F32 HL128083), the Howard Hughes Medical Institute, and a Career Development Award from the American Heart Association (19CDA34670044). Flow cytometric data were acquired using equipment maintained by the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children’s.

Contact Information

Nick Miller
513-803-6035
nicholas.miller@cchmc.org

Connect with Cincinnati Children’s

Read the Cincinnati Children's Blog.
Donate to Cincinnati Children's.
I Want To

Schedule an AppointmentMake a ReferralFind an Urgent CareFind a Doctor / ResearcherPay a BillSign into MyChartRequest Medical Records

Explore

Locations and DirectionsClinical ServicesConditions and TreatmentsVisitor and Patient InformationClinical TrialsEvents

About Us

About Cincinnati Children’sCareersNewsroomContact UsDownload our Caren AppTerms of Use / Privacy PoliciesNon-Discrimination Notice

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462

© 1999-2019 Cincinnati Children’s Hospital Medical Center. All rights reserved.

Ranked No. 3 in the U.S. News & World Report list of Best Children’s Hospitals.
Best Places to Work Logo

10 Comments

  1. Do you have a spam issue on this blog; I also am a blogger, and I was wanting to know your situation; we have developed some nice procedures and we are looking to swap methods with others, please shoot me an email if interested.

    Like

  2. Hi there would you mind sharing which blog platform you’re using? I’m planning to start my own blog in the near future but I’m having a difficult time making a decision between BlogEngine/Wordpress/B2evolution and Drupal. The reason I ask is because your design seems different then most blogs and I’m looking for something completely unique. P.S My apologies for getting off-topic but I had to ask!

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s